AdVanceXP male sling: 2-year results of a multicentre study.

Abstract

For the treatment of persistent post-prostatectomy incontinence (PPI), several surgical treatment options including male slings are available. In 2010, the second generation of the retrourethral male sling Advance, AdVanceXP, was introduced. Aim of the study was to examine in a prospective multicentre study the outcome of AdVanceXP in the treatment of PPI. Ninety-four patients were treated with AdVanceXP. Patients with nocturnal incontinence, previous incontinence surgery, with coaptive zone <1cm and irradiated patients were excluded. Measurements included: daily pad usage, 24-h pad weight test, post-operative pain in the visual analogue scale, International Quality of Life questionnaire, International Consultation on Incontinence Questionnaire short form, IEEF5 and Patient Global Impression of Improvement. Adverse events were recorded. All patients with no pads and 0-5g in the 24-h pad test were defined as cured and those with a reduction in urine loss >50% as improved. Preoperatively, the median 24-h pad weight test was 274g and daily pad usage was 3. At 1-year follow-up, 66.3% of patients could be classified as cured and 25.3% as improved. After 2years, 73.1% could be classified as cured and 19.6% as improved. Urine loss decreased (p<0.001), and quality of life improved significantly (p<0.001). Mean PGI was 1.5 after 1year and 1.4 after 2years. Majority of complications were minor. No intraoperative complications and five serious post-operative events occurred (grade IIIB complications). No explantation was necessary. AdVanceXP, when correctly indicated, shows good effectiveness and low complication rates after up to 2years.